Renaissance Capital logo

DOVA News

US IPO Weekly Recap: Blue Apron breaks in a busy week for IPOs

APRN

Eight deals priced this week, raising a combined $740 million. Meal-kit unicorn Blue Apron led the pack along with two banks, four biotechs and an enterprise storage provider. The week also saw one SPAC IPO and one Reg A+ offering. Before this week, the...read more

Hot blooded: Dova Pharmaceuticals prices upsized IPO at $17, the high end of the range

Dova Pharmaceuticals logo

Dova Pharmaceuticals, which is commercializing an acquired drug candidate for low blood platelets, raised $75 million by offering 4.4 million shares at $17, the high end of the range of $15 to $17. Dova Pharmaceuticals plans to list on the Nasdaq under the...read more

Platelet biotech Dova Pharmaceuticals sets terms for $65 million IPO

Dova Pharmaceuticals logo

Dova Pharmaceuticals, which is commercializing an acquired drug candidate for low blood platelets, announced terms for its IPO on Monday. The Durham, NC-based company plans to raise $65 million by offering 4.1 million shares at a price range of $15 to $17....read more

US IPO Weekly Recap: Blue Apron delivers its IPO filing

APRN

KBL Merger Corp. IV (KBLMU) raised $100 million in the year's 11th SPAC IPO - the only offering during a short holiday week. However, the biggest news arrived on Thursday when meal kit unicorn Blue Apron filed for a US IPO.  ...read more